Abstract
A persistent problem in the clinical management of primary melanoma is the detection of cryptic foci of metastatic melanoma. A specific chemical assay for tyrosinase or for one or more of the intermediates in the tyrosine-to-melanin metabolic pathway would be of value in estimating the degree of dissemination of the tumor. Such a test would prevent mutilating surgery or the use of a powerful and potentially injurious chemotherapeutic agent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.